PREPARED COMBINED FOR USE IN DEMENTIA, CONTAINING AT LEAST A COMPOSITION THAT HAS AN EFFECTIVE OF INHIBITION OF ACETYLCOLINE ESTERASE OR A MUSCLE EFFECT AND A COMPOUND THAT RAISES THE EXTRACELLULAR ADENOSIN ENDOGENE LEVEL

摘要

A combination of the following components for simultaneous, separate or sequential administration is new: (a) an acetylcholinesterase inhibitor or compound with muscarinergic activity, (b) a compound that increases endogenous extracellular adenosine levels, and (c) a pharmaceutical carrier.